| |
Submission Request to the NCCN Guidelines Panels
Please complete the following information:
Name:
Company/Organization:
Address:
Phone:
Email:
Date of request:
NCCN Guidelines Panel:
Guidelines for Submissions:
- A panel will consider scientific data including, but not limited to, reports of published trials that would be useful in evaluating therapies for inclusion in a guideline. These data may refer to either FDA approved or off label indications for drugs, biologics, diagnostics, procedures, or devices used for cancer prevention, detection, treatment, or supportive care.
- A cover letter (maximum 2 pages) should accompany the submission and include the following information:
- Request for NCCN Guidelines Panel to consider review of data for a specific indication.
- Specific changes recommended within the NCCN Guidelines. (one sentence)
- Statement of whether the submitted use is or is not FDA approved for that indication.
- Rationale for recommended change. (one sentence)
- Citation of literature support and complete articles supporting recommended change.
Information may be submitted via postal mail or e-mail.
Postal mail: Please submit 4 copies of the material to the following address:
Submission Request c/o Mary Anne Bergman
National Comprehensive Cancer Network
275 Commerce Dr, Suite 300
Fort Washington, PA 19034
E-mail: Please email one copy of the material to the submissions@nccn.org with “Submission Request” in the subject line.
The submission should be received by NCCN at least 6 weeks in advance of the panel meeting. The panel meetings schedule is available at the bottom of this page. You can expect to receive written notification of the NCCN Guidelines Panel's decision about your submission request at the time of publication.
Any questions regarding the submission process should be directed to:
Joan McClure, MS
Senior Vice President, Clinical Information & Publications
E-mail: mcclure@nccn.org Phone: 215.690.0300
Guidelines for Treatment of Cancer by Site
Name of Panel |
Meeting Date |
Type of Meeting |
Acute Myeloid Leukemia |
May 7, 2008 |
Teleconference |
Bladder Cancer |
June 6, 2008 |
Live |
Bone Cancer |
September 29, 2008 |
Teleconference |
Breast Cancer |
June 22-24, 2008 |
Live |
Central Nervous System Cancers |
October 10, 2008 |
Teleconference |
Cervical / Uterine Cancers |
July 30, 2008 |
Live |
Chronic Myelogenous Leukemia |
May 9, 2008 |
Live |
Colon / Rectal / Anal Cancers |
July 29, 2008 |
Live |
Esophageal / Gastric Cancers |
May 27, 2008 |
Teleconference |
Head and Neck Cancers |
September 5, 2008 |
Live |
Hepatobiliary Cancers |
June 19, 2008 |
Live |
Hodgkin Disease/Lymphoma |
July 25, 2008 |
Teleconference |
Kidney / Testicular Cancer |
June 16, 2008 |
Teleconference |
Melanoma |
July 11, 2008 |
Teleconference |
Multiple Myeloma |
May 15, 2008 |
Teleconference |
Myelodysplastic Syndromes |
May 12, 2008 |
Teleconference |
Neuroendocrine Tumors |
October 17, 2008 |
Live |
Non-Hodgkin’s Lymphoma |
August 11 & 12, 2008 |
Live |
Non-Melanoma Skin Cancers |
July 23, 2008 |
Teleconference |
Non-Small Cell Lung Cancer |
July 28, 2008 |
Teleconference |
Occult Primary |
May 14, 2008 |
Teleconference |
Ovarian Cancer |
October 20, 2008 |
Live |
Pancreatic Adenocarcinoma |
July 22, 2008 |
Teleconference |
Prostate Cancer |
August 15, 2008 |
Teleconference |
Small Cell Lung Cancer |
July 28, 2008 |
Teleconference |
Soft Tissue Sarcoma |
November 2008 |
Teleconference |
Thyroid Carcinoma |
November 2008 |
Teleconference |
Guidelines for Detection, Prevention, & Risk Reduction
Name of Panel |
Meeting Date |
Type of Meeting |
Breast Cancer Risk Reduction |
November 14, 2008 |
Teleconference |
Breast Cancer Screening and Diagnosis |
November7, 2008 |
Teleconference |
Cervical Cancer Screening |
September 8, 2008 |
Teleconference |
Colorectal Cancer Screening |
October 24, 2008 |
Teleconference |
Genetic/Familial High Risk Assessment: Breast and Ovarian |
November 2008 |
Teleconference |
Prostate Cancer Early Detection |
February 11, 2008 |
Live |
Guidelines for Supportive Care
Name of Panel |
Meeting Date |
Type of Meeting |
Adult Cancer Pain
|
September 18, 2008
|
Teleconference
|
Antiemesis |
August 4, 2008 |
Teleconference |
Cancer- and Treatment-Related Anemia |
April 11, 2008 |
Live |
Cancer-Related Fatigue |
September 16, 2008 |
Teleconference |
Distress Management |
October 15, 2008 |
Teleconference |
Myeloid Growth Factors |
July 21, 2008 |
Live |
Palliative Care |
September 12, 2008 |
Teleconference |
Pediatric Cancer Pain |
TBD |
TBD |
Prevention and Treatment of Cancer-Related Infections |
September 15, t 2008 |
Teleconference |
Senior Adult Oncology |
April 17, 2008 |
Teleconference |
Venous Thromboembolic Disease |
October 3, 2008 |
Live |
|
|
